Taming “The Monster” – with Koen Sandra
June 9, 2026
Ahead of ISC2026 in Prague, Koen Sandra explores how analytical scientists are rising to the challenge posed by increasingly intimidating biotherapeutics
11 min read
False
Pharma & Biopharma
Vaccine Analysis for a New Era
June 8, 2026
As vaccine technologies continue to expand, David Hage explores how analytical methods must evolve to meet growing demands for safety, quality, and activity testing
9 min read
Frontline Pharma: Robert Wethman
By James Strachan
May 25, 2026
Bristol Myers Squibb’s Robert Wethman discusses real-time spectroscopy, AI, and the next era of biopharmaceutical manufacturing
5 min read
Frontline Pharma: Sarah O’Keeffe
By James Strachan
May 8, 2026
Ahead of HPLC 2026, Eli Lilly’s Sarah O’Keeffe reflects on leadership, collaboration, and the analytical advances helping bring increasingly complex medicines to patients
11 min read
MSI Maps Uneven Drug Exposure in Ovarian Tumors
April 28, 2026
Patient-derived tumor explants reveal uneven PARP inhibitor uptake, with lysosomes acting as reservoirs for some weak-base drugs
3 min read
Fluorine Tracking Offers Safer Alternative to Radioactive Drug Metabolism Studies
April 14, 2026
ICP-MS method enables early, quantitative metabolite analysis without radiolabels
2 min read
Special Series eBook: GLP-1 Analysis
April 14, 2026
Experts explore how analytical science is meeting the challenges shaping GLP-1 therapeutics
1 min read
Raman Spectroscopy Moves to the Front Line of Pandemic Preparedness
April 13, 2026
Comprehensive review highlights label-free viral detection – and the hurdles to real-world deployment
2 min read
Frontline Pharma: Tao Chen
By James Strachan
April 10, 2026
A new series championing scientists in the pharmaceutical industry begins with Genentech’s rising star
5 min read
HTC-19 Profile: What’s Cooking in the mRNA Lab?
April 6, 2026
Jonathan Maurer of the University of Geneva discusses his work with Sanofi and Waters – and why good analytical science has a lot in common with good cooking
3 min read
